Parathyroid surgical failures with sufficient decline of intraoperative parathyroid hormone levels: Unobserved multiple endocrine neoplasia as an explanation

Archives of Surgery

Volumn 141, Issue 6, 2006, Pages 589-594

  Westerdahl, Johan ^a   Bergenfelz, Anders ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ANAMNESIS; ARTICLE; CHEMICAL ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA BASE; ENDOCRINE TUMOR; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; HORMONE DETERMINATION; HUMAN; HYPERTHYROIDISM; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PARATHYROIDECTOMY; PEROPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

ADENOMA; AGED; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; GERM-LINE MUTATION; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; MULTIPLE ENDOCRINE NEOPLASIA; PARATHYROID HORMONE; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; TREATMENT FAILURE;

EID: 33745238128     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.141.6.589     Document Type: Article

References (31)

1. Sosa JA, Udelsman R. Minimally invasive parathyroidectomy. Surg Oncol. 2003;12:125-134.
2. Duh Q-Y. Surgical approach to primary hyperparathyroidism (bilateral approach). In: Clark OH, Duh Q-Y, eds. Textbook of Endocrine Surgery. Philadelphia, Pa: WB Saunders Co; 1997:357-363.
3. Bergenfelz A, Isaksson A, Lindblom P, Westerdahl J, Tibblin S. Measurement of parathyroid hormone in patients with primary hyperparathyroidism undergoing first and reoperative surgery. Br J Surg. 1998;85:1129-1132.
4. Carneiro DM, Irvin GL III. Late parathyroid function after successful parathyroidectomy guided by intraoperative hormone assay (QPTH) compared with the standard bilateral neck exploration. Surgery. 2000;128:925-929; 935-936.
5. Irvin GL III, Prudhomme DL, Deriso GT, Sfakianakis G, Chandarlapaty SK. A new approach to parathyroidectomy. Ann Surg. 1994;219:574-579, 579-581.
6. Gordon LL, Snyder WH III, Wians F Jr, Nwariaku F, Kim LT. The validity of quick intraoperative parathyroid hormone assay: an evaluation in seventy-two patients based on gross morphologic criteria. Surgery. 1999;126:1030-1035.
7. Garner SC, Leight GS Jr. Initial experience with intraoperative PTH determinations in the surgical management of 130 consecutive cases of primary hyperparathyroidism. Surgery. 1999;126:1132-1138.
8. Weber CJ, Ritchie JC. Retrospective analysis of sequential changes in serum intact parathyroid hormone levels during conventional parathyroid exploration. Surgery. 1999;126:1139-1144.
9. Westerdahl J, Lindblom P, Bergenfelz A. Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg. 2002;137:186-190.
10. Henry JF, Iacobone M, Mirallie E, Deveze A, Pili S. Indications and results of video-assisted parathyroidectomy by a lateral approach in patients with primary hyperparathyroidism. Surgery. 2001;130:999-1004.
11. Tibblin S, Bergenfelz A. Surgical approach to primary hyperparathyroidism (unilateral approach). In: Clark OH, Duh Q-Y, eds. Textbook of Endocrine Surgery. Philadelphia, Pa: WB Saunders Co; 1997:365-371.
12. Bergenfelz A, Isaksson A, Ahren B. Intraoperative monitoring of intact PTH during surgery for primary hyperparathyroidism. Langenbecks Arch Chir. 1994;379:50-53.
13. Grimelius L, Akerstrom G, Bondeson L, et al. The role of the pathologist in diagnosis and surgical decision making in hyperparathyroidism. World J Surg. 1991;15:698-705.
14. Chandrasekharappa SC, Guru SC, Manickam P, et al. Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science. 1997;276:404-407.
15. Mulligan LM, Kwok JB, Healey CS, et al. Germ-line mutations of the RET protooncogene in multiple endocrine neoplasia type 2A. Nature. 1993;363:458-460.
16. Lokey J, Pattou F, Mondragon-Sanchez A, et al. Intraoperative decay profile of intact (1-84) parathyroid hormone in surgery for renal hyperparathyroidism: a consecutive series of 80 patients. Surgery. 2000;128:1029-1034.
17. Tonelli F, Spini S, Tommasi M, et al. Intraoperative parathormone measurement in patients with multiple endocrine neoplasia type I syndrome and hyperparathyroidism. World J Surg. 2000;24:556-563.
18. Carneiro DM, Solorzano CC, Nader MC, Ramirez M, Irvin GL III. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery. 2003;134:973-981.
19. Lee NC, Norton JA. Multiple-gland disease in primary hyperparathyroidism: a function of operative approach? Arch Surg. 2002;137:896-900.
20. Gauger PG, Agarwal G, England BG, et al. Intraoperative parathyroid hormone monitoring fails to detect double parathyroid adenomas: a 2-institution experience. Surgery. 2001;130:1005-1010.
21. Lundgren E, Rastad J, Ridefelt P, Juhlin C, Akerstrom G, Ljunghall S. Long-term effects of parathyroid operation on serum calcium and parathyroid hormone values in sporadic primary hyperparathyroidism. Surgery. 1992;112:1123-1129.
22. Hedback G, Oden A. Recurrence of hyperparathyroidism: a long-term follow-up after surgery for primary hyperparathyroidism. Eur J Endocrinol. 2003;148:413-421.
23. Bergenfelz A, Lindblom P, Tibblin S, Westerdahl J. Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg. 2002;236:543-551.
24. Westerdahl J, Lindblom P, Valdemarsson S, Tibblin S, Bergenfelz A. Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg. 2000;135:142-147.
25. Berndt I, Reuter M, Saller B, et al. A new hot spot for mutations in the RET protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab. 1998;83:770-774.
26. Farnebo F, Teh BT, Kytola S, et al. Alterations of the MEN1 gene in sporadic parathyroid tumors. J Clin Endocrinol Metab. 1998;83:2627-2630.
27. Horanyi J, Duffek L, Szlavik R, et al. Parathyroid surgical failures with misleading falls of intraoperative parathyroid hormone levels. J Endocrinol Invest. 2003;26:1095-1099.
28. Howe JR, Norton JA, Wells SA Jr. Prevalence of pheochromocytoma and hyperparathyroidism in multiple endocrine neoplasia type 2A: results of long-term follow-up. Surgery. 1993;114:1070-1077.
29. Mulligan LM, Eng C, Healey CS, et al. Specific mutations of the RET protooncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet. 1994;6:70-74.
30. Gao P, Scheibel S, D'Amour P, et al. Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1-84: implications for improvement of accurate assessment of parathyroid function. J Bone Miner Res. 2001;16:605-614.
31. Yamashita H, Gao P, Cantor T, et al. Comparison of parathyroid hormone levels from the intact and whole parathyroid hormone assays after parathyroidectomy for primary and secondary hyperparathyroidism. Surgery. 2004;135:149-156.